2. Signaling Pathways
  3. Immunology/Inflammation
  4. Mesothelin

Mesothelin

MSLN

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P99006
    Amatuximab
    		Inhibitor 99.90%
    Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium.
    Amatuximab
  • HY-P99352
    Anetumab
    		Inhibitor 98.78%
    Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor.
    Anetumab
  • HY-P990929
    Misitatug
    HY-P990929 is an MSLN-targeting IgG1κ type chimeric antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Misitatug
  • HY-P990833
    Anti-Mesothelin Antibody (YP218)
    		Inhibitor
    Anti-Mesothelin Antibody (YP218) is a kind of rabbit IgG chimeric antibody, targeting to human Mesothelin.
    Anti-Mesothelin Antibody (YP218)
  • HY-P990466
    Anti-Mesothelin Antibody
    		Inhibitor
    Anti-Mesothelin Antibody is a humanized antibody expressed in CHO that targets Mesothelin. The Anti-Mesothelin Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. For isotype control of the Anti-Mesothelin Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-Mesothelin Antibody
  • HY-171269
    Anetumab-MMAE
    Anetumab-MMAE is an antibody-drug conjugate (ADC) (Anetumab antibody (HY-P99352), Linker: VC linker, Payload: MMAE (HY-15162)). Anetumab is an anti-mesothelin (MSLN) antibody.
    Anetumab-MMAE
Cat. No. Product Name / Synonyms Application Reactivity